Given
the
concerns
of
waning
immunity
from
primary
COVID-19
vaccines
and
first
booster
dose,
we
conducted
an
on-line
cross-sectional
study
in
May
2022
to
investigate
willingness
receive
a
second
dose
or
new
vaccine
its
associated
factors.
Overall,
22.7%
participants
were
willing
be
vaccinated,
39.3%
unsure,
but
tend
willing,
25.8%
4.9%
unwilling,
7.4%
unwilling
vaccinated.
The
main
reasons
against
accepting
COVID‐19
included
about
side
effects,
opinion
that
further
vaccination
is
unnecessary,
effectiveness
uncertainties.
Males,
younger
individuals,
without
previous
diagnosis,
those
with
good/very
good
self-perceived
physical
health
significantly
more
frequently
vaccine.
Also,
increased
fear
COVID-19,
trust
decreased
willingness.
Our
results
show
some
hesitancy
unwillingness
toward
indicate
affect
public
Tropical Medicine and Infectious Disease,
Journal Year:
2022,
Volume and Issue:
7(10), P. 298 - 298
Published: Oct. 13, 2022
The
World
Health
Organization
(WHO)
recommended
coronavirus
disease
2019
(COVID-19)
booster
dose
vaccination
after
completing
the
primary
series
for
individuals
≥18
years
and
most-at-risk
populations.
This
study
aimed
to
estimate
pooled
proportion
of
COVID-19
vaccine
uptake
intention
get
among
general
populations
healthcare
workers
(HCWs).
We
searched
PsycINFO,
Scopus,
EBSCO,
MEDLINE
Central/PubMed,
ProQuest,
SciELO,
SAGE,
Web
Science,
Google
Scholar,
ScienceDirect
according
PRISMA
guidelines.
From
a
total
1079
screened
records,
50
studies
were
extracted.
Meta-analysis
was
conducted
using
48
high-quality
Newcastle-Ottawa
Scale
quality
assessment
tool.
Using
included
studies,
acceptance
198,831
subjects
81%
(95%
confidence
interval
(CI):
75–85%,
I2
=
100%).
actual
in
eight
involving
12,995
31%
CI:
19–46%,
100%),
while
have
79%
72–85%,
vaccines
HCWs
66%
58–74%),
99%).
Meta-regression
revealed
that
previous
infection
associated
with
lower
dose.
Conversely,
significantly
higher
level
uptake.
WHO
region
Americas,
which
did
not
include
any
vaccination,
77%
66–85%,
Western
Pacific
89%
84–92%,
100),
followed
by
European
region:
86%
81–90%,
99%),
Eastern
Mediterranean
59%
46–71%,
Southeast
Asian
52%
43–61%,
95).
Having
chronic
trust
effectiveness
significant
predictors
acceptance.
global
rate
is
high,
but
rates
vary
region.
To
achieve
herd
immunity
disease,
high
required.
Intensive
campaigns
programs
are
still
needed
around
world
raise
public
awareness
regarding
importance
accepting
proper
control
pandemic.
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1097 - 1097
Published: July 8, 2022
The
emergence
of
breakthrough
infections
and
new
highly
contagious
variants
SARS-CoV-2
threaten
the
immunization
in
individuals
who
had
completed
primary
COVID-19
vaccination.
This
systematic
review
meta-analysis
investigated,
for
first
time,
acceptance
booster
dose
its
associated
factors
among
fully
vaccinated
individuals.
We
followed
PRISMA
guidelines.
searched
Scopus,
Web
Science,
Medline,
PubMed,
ProQuest,
CINAHL
medrxiv
from
inception
to
21
May
2022.
found
14
studies
including
104,047
prevalence
intend
accept
a
was
79.0%,
while
unsure
12.6%,
that
refuse
14.3%.
main
predictors
willingness
were
older
age,
flu
vaccination
previous
season,
confidence
most
important
reasons
decline
adverse
reactions
discomfort
experienced
after
vaccine
doses
concerns
serious
doses.
Considering
burden
COVID-19,
high
rate
could
be
critical
controlling
pandemic.
Our
findings
are
innovative
help
policymakers
design
implement
specific
programs
order
decrease
hesitancy.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: July 25, 2022
Since
healthcare
professionals
(HCPs)
play
a
critical
role
in
shaping
their
local
communities'
attitudes
toward
vaccines,
HCPs'
beliefs
and
vaccination
are
of
vital
importance
for
primary
prevention
strategies.
The
present
study
was
designed
as
cross-sectional
survey-based
utilizing
self-administered
questionnaire
to
collect
data
about
COVID-19
vaccine
booster
hesitancy
(VBH)
among
Polish
HCPs
students
medical
universities
(MUSs).
Out
the
443
included
participants,
76.3%
were
females,
52.6%
HCPs,
31.8%
previously
infected
by
SARS-CoV-2,
69.3%
had
already
received
doses
(VBD).
Overall,
74.5%
participants
willing
receive
VBD,
while
7.9
17.6%
exhibited
hesitance
rejection,
respectively.
most
commonly
found
promoter
acceptance
protection
one's
health
(95.2%),
followed
family's
(81.8%)
community's
(63.3%).
Inferential
statistics
did
not
show
significant
association
between
VBH
demographic
variables,
e.g.,
age
gender;
however,
who
been
SARS-CoV-2
significantly
more
inclined
reject
VBD.
Protection
from
severe
infection,
community
transmission,
good
safety
profile,
favorable
risk-benefit
ratio
determinants
VBD
uptake.
Fear
post-vaccination
side
effects
one
key
barriers
accepting
which
is
consistent
with
pre-existing
literature.
Public
campaigns
need
highlight
postulated
benefits
vaccines
expected
harms
skipping
Tropical Medicine and Infectious Disease,
Journal Year:
2023,
Volume and Issue:
8(3), P. 159 - 159
Published: March 5, 2023
As
the
COVID-19
pandemic
continues
and
transitions
to
an
endemic
stage,
booster
vaccines
will
play
important
role
in
personal
public
health.
However,
convincing
people
take
boosters
be
a
key
obstacle.
This
study
systematically
analyzed
research
that
examined
predictors
of
vaccine
hesitancy.
A
search
PubMed,
Medline,
CINAHL,
Web
Science,
Scopus
uncovered
42
eligible
studies.
Globally,
average
vaccination
hesitancy
rate
was
30.72%.
Thirteen
factors
influencing
emerged
from
literature:
demographics
(gender,
age,
education,
income,
occupation,
employment
status,
ethnicity,
marital
status),
geographical
influences
(country,
region,
residency),
adverse
events,
perceived
benefit/efficacy,
susceptibility,
severity,
prior
history
infection,
recommendations,
health
knowledge
information,
skepticism/distrust/conspiracy
theories,
type.
Vaccine
communication
campaigns
interventions
for
COVID
should
focus
on
confidence,
complacency,
convenience.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(15), P. 8942 - 8942
Published: July 22, 2022
Background:
COVID-19
vaccines
were
made
available
to
the
public
by
end
of
2020.
However,
little
is
known
about
booster
dose
(CBD)
vaccine
perception
among
healthcare
workers
(HCW)
worldwide.
The
present
study
aims
assess
CBD
in
India
and
Saudi
Arabia
(SA).
Methods:
A
cross-sectional
was
conducted
HCWs
two
countries,
SA.
Data
gathered
through
use
a
self-administered
questionnaire.
convenience
sampling
technique
utilized
collect
data.
Results:
total
833
HCW
responses
collected
from
with
530
participants
303
SA
responding
Among
them,
16%
33%
unwilling
take
(p
<
0.005).
primary
reasons
for
not
being
willing
concerns
whether
would
be
effective
(32%)
probable
long-term
side
effects
(31%).
Concerns
knowing
enough
vaccination
(30%)
possibility
(28%)
Regression
analysis
showed
that
males,
urban
residents,
post-graduates
more
CBD.
Conclusion:
There
good
some
hesitancy
receiving
both
countries.
introduction
personalized
education,
risk
communication,
deliberate
policy
could
help
reduce
number
people
who
are
shot.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 623 - 623
Published: March 9, 2023
While
considerable
evidence
supports
the
safety
and
efficacy
of
COVID-19
vaccines,
a
sizable
population
expresses
vaccine
hesitancy.
As
per
World
Health
Organization,
hesitancy
is
one
top
10
hazards
to
global
health.
Vaccine
varies
across
countries,
with
India
reporting
least
was
higher
toward
booster
doses
than
previous
shots.
Therefore,
identifying
factors
determining
hesitance
(VBH)
sine
qua
non
successful
vaccination
campaign.This
systematic
review
followed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analysis
(PRISMA)
2020
standards.
A
total
982
articles
were
pooled
from
Scopus,
PubMed
Embase,
while
42
that
addressed
VBH
finally
included
further
analysis.We
identified
responsible
divided
them
into
three
major
groups:
sociodemographic,
financial,
psychological.
Hence,
17
stated
age
be
factor
hesitancy,
most
reports
suggesting
negative
correlation
between
fear
poor
outcomes.
Nine
studies
found
females
expressing
greater
males.
Trust
deficit
in
science
(n
=
14),
concerns
about
12),
lower
levels
regarding
infection
11),
worry
side
effects
8)
also
reasons
Blacks,
Democrats,
pregnant
women
showed
high
Few
have
income,
obesity,
social
media,
living
vulnerable
members
as
influencing
study
44.1%
towards
could
attributed
dominantly
low
rural
origin,
previously
unvaccinated
status,
or
individuals.
However,
two
other
Indian
reported
lack
availability
slots,
trust
government,
doses.Many
confirmed
multifactorial
nature
VBH,
which
necessitates
multifaceted,
individually
tailored
interventions
address
all
potentially
modifiable
factors.
This
chiefly
recommends
strategizing
campaign
by
evaluating
appropriate
communication
(at
both
individual
community
levels)
benefits
risk
losing
immunity
without
them.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Dec. 9, 2022
Background
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
is
evolving,the
newly
emerged
Omicron
variant
being
the
dominant
strain
worldwide,
and
this
has
raised
concerns
about
vaccine
efficacy.
purposes
of
survey
were
to
examine
extent
which
healthcare
workers
(HCWs)
intend
receive
a
second
booster
dose
COVID-19
factors
that
influence
their
willingness
accept
it.
Methods
study
was
conducted
among
HCWs
who
randomly
selected
from
four
public
hospitals
in
Campania
region,
Southern
Italy.
Results
A
total
496
answered
questionnaire
(a
response
rate
61.2%).
Among
respondents,
20.8%
indicated
score
10,
using
10-point
Likert-type
scale,
regarding
usefulness
dose.
Physicians,
believed
disease,
those
have
acquired
information
scientific
journals
more
likely
positive
attitude.
Slightly
than
half
self-reported
Respondents
believe
are
at
higher
risk
infected
SARS-CoV-2,
belief
useful
willing
main
reasons
for
had
intention
protect
family
members
patients,
whereas,
not
getting
vaccinated
or
uncertainty
does
offer
protection
against
emerging
variants
fear
its
side
effects.
younger
age,
physicians,
useful,
recommend
patients.
Conclusion
This
study's
findings
highlight
necessity
designing
implementing
educational
interventions
improving
uptake
beliefs
capacity
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1061 - 1061
Published: June 30, 2022
Given
the
concerns
of
waning
immunity
from
primary
COVID-19
vaccines
and
first
booster
dose,
we
conducted
an
online
cross-sectional
study
in
May
2022
to
investigate
willingness
receive
a
second
dose
or
new
vaccine
its
associated
factors.
Overall,
62%
participants
were
willing
be
vaccinated,
25.8%
unsure,
12.3%
unwilling
vaccinated.
The
main
reasons
against
accepting
dose/new
about
side
effects
effectiveness
opinion
that
further
vaccination
is
unnecessary.
Males,
younger
individuals,
without
previous
diagnosis,
those
with
good/very
good
self-perceived
physical
health
significantly
more
frequently
vaccine.
Additionally,
increased
fear
COVID-19,
trust
vaccinations,
decreased
was
willingness.
Our
results
show
some
hesitancy
unwillingness
toward
indicate
affects
public
opinion.
Journal of Clinical Nursing,
Journal Year:
2022,
Volume and Issue:
32(13-14), P. 3943 - 3953
Published: Nov. 7, 2022
Abstract
Aims
and
objectives
To
assess
the
levels
of
second
COVID‐19
booster
dose/new
vaccine
hesitancy
among
nurses
explore
potential
predictors
hesitancy.
Background
full
vaccination
seems
to
be
highly
effective
against
contagious
variants
SARS‐CoV‐2.
Healthcare
workers
are
at
high‐risk
group
since
they
have
experienced
high
COVID‐19‐associated
morbidity
mortality.
Design
An
on‐line
cross‐sectional
study
was
carried
out
in
Greece
May
2022,
using
a
self‐administered
questionnaire.
Methods
The
population
included
healthcare
services
who
were
fully
vaccinated
time
study.
We
considered
socio‐demographic
characteristics,
COVID‐19‐related
variables,
attitudes
toward
pandemic
as
applied
STROBE
checklist
our
Results
Among
795
nurses,
30.9%
hesitant
dose
or
new
vaccine.
Independent
lower
educational
level,
absence
chronic
condition,
good/very
good
self‐perceived
physical
health,
lack
flu
during
2021,
front‐line
that
provided
patients,
had
not
been
diagnosed
with
least
one
relative/friend
has
died
from
COVID‐19.
Moreover,
increased
compliance
hygiene
measures,
fear
decreased
trust
associated
Conclusions
Our
shows
significant
percentage
This
initial
could
barrier
efforts
control
pandemic.
Relevance
clinical
practice
Nurses'
role
is
essential
empowering
public
their
passion
empathy.
There
need
communicate
science
way
accessible
order
decrease
Patient
contribution
No
patient
contribution.
Human Vaccines & Immunotherapeutics,
Journal Year:
2023,
Volume and Issue:
19(1)
Published: Jan. 2, 2023
Coronavirus
disease
2019
(COVID-19)
has
wreaked
havoc
across
the
globe
for
approximately
three
years.
Vaccination
is
a
key
factor
to
ending
this
pandemic,
but
its
protective
effect
diminishes
over
time.
A
second
booster
dose
at
right
time
needed.
To
explore
willingness
receive
fourth
of
COVID-19
vaccine
and
influencing
factors,
we
commenced
national,
cross-sectional
anonymous
survey
in
mainland
China
among
people
aged
18
above
from
October
24
November
7,
2022.
total
3,224
respondents
were
eventually
included.
The
acceptance
rate
was
81.1%
(95%
CI:
79.8–82.5%),
while
it
72.6%
71.1–74.2%)
heterologous
booster.
Confidence
current
domestic
situation
effectiveness
previous
vaccinations,
uncertainty
about
extra
protection
main
reasons
hesitancy.
Perceived
benefit
(aOR
=
1.29,
95%
1.159–1.40)
cues
action
1.73,
1.60–1.88)
positively
associated
with
acceptance,
whereas
perceived
barriers
0.78,
0.72–0.84)
self-efficacy
0.79,
0.71–0.89)
both
negatively
it.
Additionally,
sex,
age,
vaccination
history,
social
media,
satisfaction
government's
response
also
factors
affecting
intention.
Factors
intention
similar
results.
It
profound
theoretical
practical
significance
clarify
population's
vaccinate
advance
relevant
subsequent
development
promotion
fourth-dose
strategies.